If someone has already had LASIK, can they have the EVO ICL implanted?

Most likely not as the safety and effectiveness of EVO for the correction of moderate to<a href="https://www.goodeyes.com/blog/myopia-symptoms-causes-and-treatment-options/"> high myopia</a> with and without astigmatism has not been established in patients with a previous history of ocular surgery.

What clinical studies can you reference to prove the EVO ICL?s safety and efficacy?

The most recent U.S. clinical trial of the EVO ICL reviewed by FDA is summarized in the EVO/EVO+ ICL Directions for Use (DFU) and the FDA?s Summary of Safety and Effectiveness Data (SSED) issued with the PMA Approval notice. Hundreds of peer-reviewed papers from dozens of countries report the safety and efficacy of EVO. Select papers are listed below including a comprehensive literature review of peer-reviewed papers bringing together the safety and effectiveness data from 67 preclinical studies and clinical reports. In these studies, 4,196 eyes reported safety data and 1,905 eyes reported effectiveness data. <ul style="list-style-type: disc;"> <li>Packer M. The Implantable Collamer Lens with a central port: review of the literature. Clinical Ophthalmology 2018: 12: 2427-2438.</li> <li>Martinez-Plazs E, Lopez-Miguel A, Lopez-De La Rosa A, et al. Effect of the EVO+ Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of Vision and Life, Am J Ophthalmol 2021;226: 117-125.</li> <li>Ganesh S, Brar S, Pawar A. Matched population comparison of visual outcomes and patient satisfaction between 3 modalities for the correction of low to moderate myopic astigmatism. Clin Ophthalmol. 2017;11:1253-1263</li> </ul>

EVO ICL Lens in Arizona | Barnet Dulaney Perkins Eye Center

What Is EVO ICL?

EVO ICL is a thin, flexible lens that is surgically placed behind the iris and in front of your eye’s natural lens.

The lens is made from Collamer®, a proprietary biocompatible material designed to work in harmony with the eye. Once positioned, you typically cannot see or feel the lens.

Unlike traditional contact lenses, EVO ICL remains inside the eye and does not require daily removal, cleaning, or replacement.

It is considered an additive vision correction procedure because your surgeon does not remove your natural lens or reshape your corneal tissue.

EVO ICL is intended to remain in place long term, but the lens can also be removed by an eye surgeon if medically necessary.

Benefits of EVO ICL

Provides clear, sharp vision with UV protection

Can treat nearsightedness with or without astigmatism

20 to 30 minute procedure with quick recovery time

For patients who may not be candidates for LASIK or other vision correction procedures due to thin corneas

Not visible once in place

Does not cause dry eye syndrome, which can be a potential side effect of other vision correction procedures

Removable by your doctor

Excellent night vision

Who Is a Good Candidate for EVO ICL?

Professional 40-year-old Hispanic woman heading to a meeting, illustrating an active lifestyle for patients exploring EVO ICL after 40 at Barnet Dulaney Perkins Eye Center.

EVO ICL is FDA approved for appropriately selected adults ages 21 through 60 with moderate to severe nearsightedness.

You may be a candidate if you:

Are between 21 and 60 years old
Have moderate to severe nearsightedness
Have nearsightedness with or without astigmatism
Have had a relatively stable vision prescription
Have healthy eyes
Have enough space inside the eye to safely accommodate the lens
Want to reduce your dependence on glasses or contact lenses
Are looking for an alternative to corneal laser vision correction

During your FREE vision correction consultation, your eye doctor will take detailed measurements of your eyes and consider your prescription, corneal health, internal eye anatomy, age, lifestyle, and long-term vision goals.

EVO ICL Compared To Other Vision Correction Procedures

Correction	EVO ICL	LASIK	Refractive Lens
	The EVO ICL (Implantable Collamer Lens) is an implant that corrects vision without removing any corneal tissue	LASIK is a two-step laser vision correction surgery where a flap is made on the surface of the eye called the cornea, and the underlying layers are reshaped with an excimer laser to correct vision.	During Refractive Lens Exchange surgery, the natural crystalline lens is removed and replaced with an Intraocular lens implant, or IOL. The lOL that replaces the natural lens corrects the patient’s vision.
Nearsightedness	Moderate to Severe	Mild to Moderate	Mild to Severe
Farsightedness	No	Yes	Mild to Severe
Astigmatism	Yes	Yes	Mild to Moderate
Thin Cornea	Yes	Limited	Yes

How Does The EVO ICL Procedure Work?

Pre-Op Eye Exam

Your Eyes Are Numbed Using Drops

Small Opening Is Created

The EVO ICL Is Inserted & Positioned

Post Op/Follow-Up

EVO ICL Procedure & Patient Experiences

EVO Implantable Collamer Lens used for vision correction in eligible patients exploring EVO ICL after 40 at Barnet Dulaney Perkins Eye Center.

Download STAAR Surgical’s Guide To EVO ICL

This free guide is meant to help people who need vision correction make decisions. You will learn about:

How EVO works
Benefits of EVO ICL
The procedure

Download in English Download in Spanish

Is EVO ICL an Option After 40?

EVO ICL after 40 may be an option for adults with a healthy natural lens who primarily want to correct…

Is Vision Correction Surgery Safe? LASIK, PRK, RLE and EVO ICL

Vision correction can be a safe and effective way to reduce dependence on glasses or contact lenses. LASIK, PRK, RLE,…

Contact Lens Intolerance: Causes & Relief Tips

Many of our patients with refractive errors prefer contact lenses to glasses for various reasons. Unlike glasses, contacts don’t alter…

Explore Your Vision Correction Options

LASIK

LASIK reshapes the cornea beneath a thin flap to improve focusing, and it’s commonly used to treat myopia, hyperopia, and astigmatism.

PRK

PRK is a surface laser procedure that reshapes the cornea without creating a corneal flap.

EVO ICL

EVO ICL is a lens implant placed behind the iris and in front of your natural lens to correct nearsightedness, with or without astigmatism.

Refractive Lens Exchange

RLE is an elective lens replacement procedure in which your natural lens is removed and replaced with an IOL.

Frequently Asked Questions About EVO ICL

EVO is a revolutionary solution for vision correction. It is a clinically-proven implantable lens designed to address common vision problems, including nearsightedness and nearsightedness with astigmatism, which is the need for distance vision correction. EVO offers an option for those looking to eliminate their dependence on glasses or contact lenses.

Both EVO and LASIK are effective vision correction options. EVO offers a great way to break free from glasses and contact lenses while not having to remove corneal tissue as in laser vision correction procedures. The EVO lens is additive; meaning, it is implanted in the eye and doesn’t remove corneal tissue. The EVO lens works in harmony with the natural eye while delivering sharp, clear vision, excellent night vision, UV protection, and does not cause dry eye syndrome. If desired, the EVO lens is removable by a doctor providing patients added peace of mind.

Both options are FDA-approved as safe and effective. EVO can be a better choice for many patients compared to contact lenses for several reasons, including efficiency, cost, and convenience. On average, the lifetime cost of contact lenses can reach approximately $12,000, though your personal expenses may vary. Since EVO offers a long-term solution, the procedure is generally associated with a one-time fee, making it a more economical choice over time. When comparing the long-term costs of contact lenses, EVO often pays for itself. Additionally, EVO lenses liberate wearers from the daily inconvenience and maintenance required for contacts and glasses.

The EVO ICL lens is made from Collamer, a collagen co-polymer that is proprietary to STAAR Surgical. Collamer is biocompatible, stable, and flexible, thus making it an ideal lens material for the eye. It has a long history of successful in-eye use.

Most likely not as the safety and effectiveness of EVO for the correction of moderate to high myopia with and without astigmatism has not been established in patients with a previous history of ocular surgery.

EVO is a globally trusted and proven procedure. According to a survey conducted by STAAR, 99.4% of patients said they would choose the EVO procedure again. Over 1,000,000 EVO ICL lenses have been implanted worldwide. The U.S. FDA has confirmed that the EVO ICL is a safe and effective treatment for moderate to high nearsightedness, with or without astigmatism, for patients in the United States.

The most recent U.S. clinical trial of the EVO ICL reviewed by FDA is summarized in the EVO/EVO+ ICL Directions for Use (DFU) and the FDA?s Summary of Safety and Effectiveness Data (SSED) issued with the PMA Approval notice. Hundreds of peer-reviewed papers from dozens of countries report the safety and efficacy of EVO. Select papers are listed below including a comprehensive literature review of peer-reviewed papers bringing together the safety and effectiveness data from 67 preclinical studies and clinical reports. In these studies, 4,196 eyes reported safety data and 1,905 eyes reported effectiveness data.

Packer M. The Implantable Collamer Lens with a central port: review of the literature. Clinical Ophthalmology 2018:
12: 2427-2438.
Martinez-Plazs E, Lopez-Miguel A, Lopez-De La Rosa A, et al. Effect of the EVO+ Visian Phakic Implantable
Collamer Lens on Visual Performance and Quality of Vision and Life, Am J Ophthalmol 2021;226: 117-125.
Ganesh S, Brar S, Pawar A. Matched population comparison of visual outcomes and patient satisfaction between 3
modalities for the correction of low to moderate myopic astigmatism. Clin Ophthalmol. 2017;11:1253-1263

Both EVO and LASIK are effective options for vision correction. EVO provides a way to free yourself from glasses and contact lenses without the need to remove corneal tissue, which is a requirement in laser vision correction procedures. The EVO lens is additive; this means it is implanted in the eye without removing any corneal tissue. It works in harmony with the natural eye, delivering sharp, clear vision, excellent night vision, and UV protection, all while avoiding the risk of dry eye syndrome. Additionally, if desired, the EVO lens can be removed by a doctor, offering patients extra peace of mind.

Most likely not as the safety and effectiveness of EVO for the correction of moderate to high myopia with and without astigmatism has not been established in patients with a previous history of ocular surgery.